文献速递呼吸衰竭与机械通气

电磁导航支气管镜下针吸联合钳夹活检对外周肺病灶的诊断率及协同作用:一项随机对照试验

Diagnostic Yield and Synergistic Impact of Needle Aspiration and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: A Randomized Controlled Trial.
PubMed 文献 · Chest · 2025-02-22
一句话结论中度镇静下电磁导航支气管镜诊断外周肺病灶时,针吸联合钳夹活检较任一单用可显著提高诊断率(66.9% vs 钳夹44.4%、针吸51.4%)和恶性病变灵敏度(71.7% vs 47.5%、58.3%)。

该随机交叉试验纳入需活检、适合择期电磁导航支气管镜(ENB)的外周肺病灶患者,在中度镇静下按随机顺序先后行ENB引导针吸和钳夹活检,主要终点为可指导患者管理的具体诊断率。142例入组、140例获完整随访,诊断率钳夹活检44.4%(63/142)、针吸51.4%(73/142,P=0.221 vs 钳夹)、联合66.9%(95/142,P<0.001 vs 单用钳夹,P<0.001 vs 单用针吸)。恶性病变灵敏度钳夹47.5%(57/120)、针吸58.3%(70/120,P=0.074),联合71.7%(86/120,P<0.001 vs 单用钳夹和单用针吸)。气胸发生率3.5%(5/142),需管引流的气胸1.4%(2/142)。作者认为针吸与钳夹联合的多模态方式是ENB的有效诊断策略。

要点

  • 中度镇静下ENB诊断外周肺病灶,联合针吸+钳夹活检诊断率66.9%(95/142),显著高于单用钳夹44.4%(P<0.001)和单用针吸51.4%(P<0.001)。
  • 联合两种器械对恶性病变灵敏度71.7%(86/120),显著高于单用钳夹47.5%和单用针吸58.3%(P<0.001)。
  • 单用针吸与单用钳夹比较:诊断率51.4% vs 44.4%(P=0.221),恶性病变灵敏度58.3% vs 47.5%(P=0.074),均未达统计学显著。
  • 安全性:气胸3.5%(5/142),其中需管引流1.4%(2/142)。
  • 作者认为,使用针吸和钳夹的多模态方式是ENB的有效诊断策略。

适用人群与场景

  • 需活检、适合择期电磁导航支气管镜(ENB)的外周肺病灶患者,在中度镇静下操作。

诊断标准与关键阈值

  • 诊断率定义为活检提供可指导患者管理的具体诊断的患者百分比。

处置流程与药物剂量

  • 在中度镇静下行ENB,按随机顺序先后进行ENB引导的针吸和钳夹活检。

研究设计与关键结果

  • 随机交叉试验,2021年12月1日至2023年11月13日入组142例并完成研究操作,140例获完整随访数据。
  • 诊断率:钳夹活检44.4%(63/142),针吸51.4%(73/142)(P=0.221 vs 钳夹),联合66.9%(95/142)(P<0.001 vs 单用钳夹,P<0.001 vs 单用针吸)。
  • 恶性病变灵敏度:钳夹活检47.5%(57/120),针吸58.3%(70/120)(P=0.074);联合71.7%(86/120)(P<0.001 vs 单用钳夹和单用针吸)。
  • 气胸发生率3.5%(5/142),需管引流的气胸1.4%(2/142)。

证据类型、等级与局限

  • 随机交叉试验(ClinicalTrials.gov注册号NCT05110131)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在中度镇静下行ENB时,针吸与钳夹活检联合较任一单用可显著提高诊断率和恶性病变灵敏度,且安全性良好;使用针吸和钳夹的多模态方式是ENB的有效诊断策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Electromagnetic navigation bronchoscopy (ENB) is an advanced imaging-guided technique used to diagnose peripheral pulmonary lesions. However, the optimal strategy for selecting biopsy devices remains unclear.

RESEARCH QUESTION: Does the combination of needle aspiration and forceps biopsy improve diagnostic yield compared with using a single device alone?

STUDY DESIGN AND METHODS: We conducted a randomized crossover study during ENB performed under moderate sedation. This trial recruited participants with peripheral pulmonary lesions requiring biopsy who were eligible for elective ENB. ENB-guided needle aspiration and forceps biopsy were sequentially performed in a randomized order. The primary outcome was diagnostic yield, defined as the percentage of patients for whom the biopsy provided a specific diagnosis able to inform patient management. The diagnostic yield achieved by each biopsy modality individually and in combination was evaluated.

RESULTS: Between December 1, 2021, and November 13, 2023, 142 participants were enrolled and underwent the study procedures. Complete follow-up data were obtained for 140 participants. Diagnostic yield was 44.4% (63 of 142) for forceps biopsy, 51.4% (73 of 142) for needle aspiration (P = .221 vs forceps), and 66.9% (95 of 142) for the combination (P < .001 vs forceps alone, P < .001 vs needle alone). Sensitivities for malignancy were 47.5% (57 of 120) for forceps biopsy and 58.3% (70 of 120) for needle aspiration (P = .074). The combination of the 2 modalities resulted in a significantly improved sensitivity of 71.7% (86 of 120) compared with either individual modality (P < .001 vs forceps alone and needle alone). Pneumothorax occurred in 3.5% (5 of 142) of patients, and 1.4% (2 of 142) developed pneumothorax requiring tube drainage.

INTERPRETATION: Our results show that when performing ENB under moderate sedation, the combination of needle aspiration and forceps biopsy significantly improves the diagnostic yield and sensitivity for malignancy compared with each modality alone, with a favorable safety profile. These results indicate that a multimodal approach using needles and forceps is a valid diagnostic strategy for ENB.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05110131; URL: www.

CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Kim YW, Kim HJ, Kwon BS, et al. Diagnostic Yield and Synergistic Impact of Needle Aspiration and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: A Randomized Controlled Trial. Chest. 2025. PMID: 39993594. doi:10.1016/j.chest.2025.02.015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。